Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
Open Access
Abstract
The focus of treating cancer with oncolytic viruses (OVs) has increasingly shifted towards achieving efficacy through the induction and augmentation of an antitumor immune response. However, innate antiviral responses can limit the activity of many OVs within the tumor and several immunosuppressive factors can hamper any subsequent antitumor immune responses. In recent decades, numerous small molecule compounds that either inhibit the immunosuppressive features of tumor cells or antagonize antiviral immunity have been developed and tested for. Here we comprehensively review small molecule compounds that can achieve therapeutic synergy with OVs. We also elaborate on the mechanisms by which these treatments elicit anti-tumor effects as monotherapies and how these complement OV treatment.Keywords
Funding Information
- Christian Doppler Forschungsgesellschaft (n.a.)
This publication has 303 references indexed in Scilit:
- Synergistic combination of valproic acid and oncolytic parvovirus H‐1PV as a potential therapy against cervical and pancreatic carcinomasEMBO Molecular Medicine, 2013
- The Membrane-Bound Transcription Factor CREB3L1 Is Activated in Response to Virus Infection to Inhibit Proliferation of Virus-Infected CellsCell Host & Microbe, 2011
- Consequence of dose scheduling of sunitinib on host immune response elements and vaccine combination therapyInternational Journal of Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Targeting immune suppressing myeloid-derived suppressor cells in oncologyCritical Reviews in Oncology/Hematology, 2011
- Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsCancer Immunology, Immunotherapy, 2010
- Effect of a small molecule BCL‐2 inhibitor on immune function and use with a recombinant vaccineInternational Journal of Cancer, 2010
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progressionTrends in Immunology, 2010
- Autocrine TNFα Signaling Renders Human Cancer Cells Susceptible to Smac-Mimetic-Induced ApoptosisCancer Cell, 2007
- The Hallmarks of CancerCell, 2000